Results 51 to 60 of about 44,324 (216)

GLP‐1 agonist‐associated presentations to unscheduled care: An opportunistic pilot study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The impact of GLP‐1 or GIP/GLP‐1 receptor agonist use on unscheduled care is not well‐described. We conducted a prospective, observational study using opportunistic screening by clinicians as a first step to understanding the effect of GLP‐1 or GIP/GLP‐1 agonists on Emergency Department presentations and to guide future studies.
Oliver Thomas, James Michael Coulson
wiley   +1 more source

Altered microbiome of serum exosomes in patients with acute and chronic cholecystitis

open access: yesBMC Microbiology
Background This study aimed to investigate the differences in the microbiota composition of serum exosomes from patients with acute and chronic cholecystitis.
Qing Zhu   +8 more
doaj   +1 more source

Bile Peritonitis in Acute Cholecystitis [PDF]

open access: yes, 1990
A review of all patients treated for acute cholecystitis (n = 5848) during an 18-year period (1969-1986) at two hospitals (one practising early surgery in patients with acute cholecystitis and the other not) disclosed that 104 (1.8%) had bile within the ...
Andersson, R, Bengmark, S, Tranberg, KG
core   +3 more sources

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Hematologic malignancies represent the most common cancers in children. While the mainstays of treatment are chemotherapy and potentially hematopoietic stem cell transplant, minimally invasive surgery (MIS) has a role in the diagnosis and management of complications related both to disease and therapy as well as common pediatric surgical ...
Alejandro Chara   +3 more
wiley   +1 more source

A Case Report of Acute Acalculous Cholecystitis and Acute Hemorrhagic Cystitis due to Salmonella Typhi

open access: yesCase Reports in Medicine, 2014
Acute acalculous cholecystitis and acute hemorrhagic cystitis due to Salmonella Typhi are a rare condition. A 24-year-old female patient was admitted to our clinic with abdominal pain, nausea, fever, headache, urinary burning, and bloody urine.
Hatice Beyazal Polat   +2 more
doaj   +1 more source

Predictive Models of Gangrenous Cholecystitis in Laparoscopic Cholecystectomy Treated Patients [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Introduction: Gangrenous cholecystitis is difficult to diagnose clinically. There are no distinctive signs, symptoms or laboratory findings to distinguish it from acute cholecystitis.
Dhaval O Mangukiya   +6 more
doaj   +1 more source

Liver Resection for Hepatic Adenoma [PDF]

open access: yes, 1979
Between 1970 and 1978, eight hepatic adenomas were resected. Four of the eight patients took oral contraceptive pills before the hepatic adenoma was identified; one patient was male. Four patients had evidence of bleeding at the time of presentation. The
Koep, LJ, Starzl, TE, Weil, R
core   +1 more source

Acute cholecystitis

open access: yesActa chirurgica Iugoslavica, 2003
Only 20 - 30% of patients with gallstones have symptoms and the probability of a patient with silent gallstones developing biliary-related pain is 1- 2% while the risk of developing a serious complication (e.g. empyema, perforation, peritonitis etc.) is less than 0.1% per year.
openaire   +3 more sources

Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
We assessed four different doses of ME3183, a novel phosphodiesterase 4 inhibitor, and placebo in 132 patients with moderate to severe plaque psoriasis. At Week 16, more patients receiving ME3183 achieved ≥75% reduction in baseline Psoriasis Area and Severity Index scores than those receiving placebo, with no new safety concerns.
Kim A. Papp   +5 more
wiley   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 Diabetes

open access: yesJournal of the American Geriatrics Society, EarlyView.
Effect of glucagon‐like peptide‐1 receptor agonist therapy on cardiorenal outcomes in patients aged ≥ 80 years with Type 2 diabetes. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated potential in improving glycemic control and reducing adverse outcomes in patients with Type 2 diabetes mellitus (T2DM); however ...
Jui‐Cheng Chen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy